Alicja Puszkiel

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

From Clinical Trials to Real-World Patients: Population Pharmacokinetics and Precision Dosing Simulations of Lorlatinib.

From Clinical Trials to Real-World Patients: Population Pharmacokinetics and Precision Dosing Simulations of Lorlatinib.

Journal: Clinical pharmacokinetics

Published: May 20, 2026

Therapeutic Drug Monitoring and Model-Informed Precision Dosing of Oral TKIs and PARP Inhibitors: A Practical Framework for Clinical Implementation.

Therapeutic Drug Monitoring and Model-Informed Precision Dosing of Oral TKIs and PARP Inhibitors: A Practical Framework for Clinical Implementation.

Journal: Clinical pharmacokinetics

Published: February 25, 2026

Correction: Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.

Correction: Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.

Journal: British journal of cancer

Published: January 20, 2026

The hidden impact of renal impairment on ribociclib exposure and co-medications: a case report.

The hidden impact of renal impairment on ribociclib exposure and co-medications: a case report.

Journal: Cancer chemotherapy and pharmacology

Published: December 19, 2025

Population pharmacokinetics of encorafenib and binimetinib in real-world patients with BRAFV600E/K-mutant metastatic melanoma.

Population pharmacokinetics of encorafenib and binimetinib in real-world patients with BRAFV600E/K-mutant metastatic melanoma.

Journal: Cancer chemotherapy and pharmacology

Published: November 06, 2025

Shared and distinct effects of mood stabilizers on epigenetic machinery gene expression: an exploratory study in HeLa cells.

Shared and distinct effects of mood stabilizers on epigenetic machinery gene expression: an exploratory study in HeLa cells.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: October 02, 2025

Exposure-response relationship of nivolumab and ipilimumab in patients with metastatic renal cell carcinoma from the randomised phase 2 BIONIKK study.

Exposure-response relationship of nivolumab and ipilimumab in patients with metastatic renal cell carcinoma from the randomised phase 2 BIONIKK study.

Journal: British journal of cancer

Published: June 25, 2025

LC-MS/MS method for quantification of avacopan in human plasma from patients treated for antineutrophil cytoplasmic antibody-associated vasculitis.

LC-MS/MS method for quantification of avacopan in human plasma from patients treated for antineutrophil cytoplasmic antibody-associated vasculitis.

Journal: Journal of pharmaceutical and biomedical analysis

Published: June 18, 2025

Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring.

Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: May 22, 2025

Role of cytochrome phenotyping in patients with chronic noncancer pain with inadequate response to tramadol.

Role of cytochrome phenotyping in patients with chronic noncancer pain with inadequate response to tramadol.

Journal: Pain reports

Published: April 07, 2025

Comparison of rituximab induction and maintenance regimens in anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: PK/PD modelling of ANCA and gammaglobulin levels in real-world patients.

Comparison of rituximab induction and maintenance regimens in anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: PK/PD modelling of ANCA and gammaglobulin levels in real-world patients.

Journal: EBioMedicine

Published: March 18, 2025

Prediction of a CLDN18.2 Targeted Antibody Drug Conjugate Pharmacokinetics in Cancer Patients Using PBPK Modeling and Simulation.

Prediction of a CLDN18.2 Targeted Antibody Drug Conjugate Pharmacokinetics in Cancer Patients Using PBPK Modeling and Simulation.

Journal: CPT: pharmacometrics & systems pharmacology

Published: February 26, 2025

Showing 1-12 of 44

Last Updated: 09/26/2026